Invion Ltd has released a press release.
Response to ASX Appendix 4C Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Invion completes spin-out of respiratory assets
- General Meeting - Results of Meeting
- Appendix 4C - December quarter
- Appendix 4C - September 2018 quarter
- New Photosoft formulation increased effect in ovarian cancer
Later from Invion
- Appendix 4D and Financial Report for Half Year to 31 Dec 18
- Quarterly Update
- Animal studies show IVX-P02 potential in metastatic cancers
- Appendix 4C - June quarter
- COO Craig Newton to transition to Invion CEO
Follow Invion into a list and get an email when it puts out news.
Follow Invion